Leteprinim Potassium

N/A

Report date: 2022/11/25 17:31:17
NME

Base Information

Drug NameLeteprinim Potassium
Drug Alias Nameleteprinim来普立宁钾leteprinimumNeotrofinNeotrophin +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-nerve growth factor modulators
TargetsBeta-nerve growth factor
Therapy Area/IndicationsPeripheral Nervous System DiseasesMemory Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSpectrum Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeotherapeutics LlcNational Institute On Aging (NIA)
Active IndicationsN/A
Inactive IndicationsPeripheral Nervous System DiseasesMemory Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG